Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland

29 Nov 2023

LUGANO, Switzerland – The ESMO Immuno-Oncology Congress 2023, where experts discuss the latest scientific developments in this fast-moving field of cancer treatment, will be held in Geneva, Switzerland, between 6-8 December, also with a virtual component.

Programme highlights

  • Novel data, new insights, and reinforced potential of the use of Tumour Infiltrating Lymphocytes (TIL) therapy in patients with melanoma
    Related content: 119O, 48O, 50MO, 66MO, Educational session on Thursday, 7 December at 8:30 CET
  • New therapeutic approaches in nasopharyngeal carcinoma and in relapsed/refractory solid tumours
    Related content: 67MO and 118O
  • Further evidence of failures of Tyrosine Kinase Inhibitor (TKI) and Immune Checkpoint Inhibitors (CPI) combination in non-small cell lung cancer: Insights for future research directions
    Related content: 64O, 65O, Educational session on Wednesday, 6 December at 16:15 CET

Award keynote lecture

The results of 220 studies will be presented and published online as a supplement to IOTECH.

Press registration

ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities. To apply for press accreditation, please fill out the form available here. Requests for press accreditation should be sent by Tuesday, 5 December. Please be kindly informed that onsite press accreditation will not be possible.

Further information

ESMO Press Office

Notes to editors

Please make sure to use the official name of the meeting in your reports: ESMO Immuno-Oncology Congress 2023 and the official congress hashtag #ESMOImmuno23. Follow it to stay up to date and use it to take part in the conversation on X (Twitter), LinkedIn, Instagram, Facebook 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.